ACC.21 Wrap: Payal Kohli, MD, Talks Late Breakers and Thinking Big About Treating Novel Disease
By DocWire News Editors - Last Updated: April 19, 2023DocWire News Medical Lead Payal Kohli, MD, FACC, talks about her favorite research coming out of the recently wrapped-up ACC.21 Scientific Session. Some of the topics include the LAAOS results, the ADAPTABLE study, the all-digital vs. in-person meeting formats, and more.
Advertisement
More From ACC.21
Read Exclusive Commentary from Dr. Eugene Braunwald on the LIFE trial results.
Read Exclusive Commentary from Dr. Hugh Calkins on the RAFT-AF trial results.
Read more DocWire News ACC.21 Conference Coverage, with Excusive Content from the CardioNerds team of correspondents.
Advertisement
Related Posts
Editor’s Note: This dispatch from ACC.21 was written by Kelly Arps, MD, a cardiology fellow at Duke University. Dr. ...
Editor’s Note: This dispatch from ACC.21 was written by Daniel Pipilas, MD, a general cardiology fellow at ...
New study results from the American College of Cardiology Scientific Session (ACC.21) suggest that clopidogrel was ...
Editor's Note: This dispatch from ACC.21 was written by Mark Belkin, MD, a cardiology fellow at the University of ...
New research suggests that alcohol consumption is associated with a rapid increase in the risk for atrial fibrillation ...
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.